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Organic compounds of mercury have a variety
of industrial uses, and most of the data relating
to the neurotoxic effects of mercury exposure
have been derived from occupational popula-
tions (Chipman et al. 1995). However, in the
1950s a potential risk to the wider community
was highlighted when large numbers of people
living in the Minamata Bay area of Kyushu
Island, Japan, developed symptoms of mercury
poisoning. This well-documented incident was
traced to a factory using mercuric chloride as a
catalyst in the production of vinyl chloride and
discharging efﬂuent into the sea (Harada 1995).
In aquatic environments, mercury is methylated
by the action of common bacteria and
methylmercury (MeHg), then passes up the
food chain and becomes concentrated in ﬁsh
and sea mammals. The heavy dependence of the
Minamata inhabitants on a ﬁsh diet meant that
they were subject to high levels of MeHg expo-
sure. Both marine and freshwater ﬁsh routinely
contain low levels of MeHg as a result of mer-
cury leaching from the earth’s crust. Cases of
frank poisoning have not been recorded in ﬁsh-
eating populations other than those in
Minamata, where special circumstances pre-
vailed. However, the Minamata ﬁndings raised
questions about whether less severe neurologic
effects might occur at lower levels of exposure in
populations whose diets were rich in seafood. 
Given the high level of fetal abnormalities
observed in Minamata (Harada 1995), par-
ticular concern focused on the potentially
hazardous effects of prenatal exposure. This
concern increased after an outbreak of mercury
poisoning in Iraq in 1971–1972, when large
numbers of people consumed bread made from
grain treated with a mercury-based fungicide.
Subsequent neurologic examination of 80 chil-
dren born to mothers who had eaten the
affected bread over a 2- to 3-month period sug-
gested an increase in neurologic abnormalities
(Amin-Zaki et al. 1974). Animal and other
data have indicated that the developing fetus is
more vulnerable both to exposure to neuro-
toxicants such as heavy metals and to the effects
of such exposure (Hanson 1997). Any adverse
effects are likely to be structurally and function-
ally different from those seen in the exposed
adult. Thus, in addition to the obvious concern
for the health of those with diets high in
seafood, this issue has wider public health
implications in terms of the general advisability
of consuming seafood during pregnancy. 
The systematic investigation of potential
developmental effects in children after prenatal
exposure to MeHg began in the 1980s. Since
that time two major longitudinal programs of
work and a number of smaller cross-sectional
studies have been conducted. These investiga-
tions assessed levels of prenatal exposure to
MeHg in seafood-eating populations and
examined subsequent developmental outcomes
in children of varying ages. However, despite
considerable research effort over a period of
20 years, there remains a lack of consensus on
the central issue of whether exposure to MeHg
derived from the routine diets of pregnant
women presents a risk to their unborn children.
This article contributes to the current debate
on this subject with a brief description of the
currently available data, some possible explana-
tions for the inconclusive results that have so far
emerged, and suggestions for potential ways
forward in this contentious area of research. 
Current Evidence
A search of relevant databases [Medline
(http://omni.ac.uk/medline), Toxﬁle (http://
www.dialog.com), Embase (http://www.
embase.com), Cancerlit (http://cancerweb.
ncl.ac.uk/cancernet/cancerlit/), Biosis Previews
(http://www.biosis.org.uk), SciSearch (http://
www.bids.ac.uk), and the  Web of Science
(http://wok.mimas.ac.uk)], using keywords
such as “methylmercury,” “prenatal exposure,”
“child development,” and “neurobehavior,”
revealed that 12 investigations have been pub-
lished thus far on this subject, all of which
have been conducted since 1980.These investi-
gations have used either neurologic exami-
nations, developmental rating scales, or
psychological tests to evaluate postnatal neuro-
logic effects in children prenatally exposed to
MeHg. Nine of the studies were cross-sectional
(Table 1), in the sense that a sample of chil-
dren was tested on one occasion and associa-
tions between test results and a measure of
prenatal exposure to MeHg were examined.
(Cordier et al. 2002; Grandjean et al. 1999b;
Kjellstrom 1991; Marsh et al. 1995b;
McKeown-Eyssen et al. 1983; Murata et al.
1999b; Steuerwald et al. 2000; Stewert et al.
2003; Weihe et al. 2002). Of these cross-
sectional studies, however, one consisted of a
form of follow-up, in that children were tested
at 6–7 years of age and divided into compari-
son groups on the basis of exposure data col-
lected from their mothers soon after birth
(Crump et al. 1998; Kjellstrom 1991). In
addition the study of Stewert et al. (2003)
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I conducted a review of the published literature to assess the strength of the evidence for an association
between prenatal exposure to methylmercury (MeHg) and subsequent child development. 
I identiﬁed 12 studies on this subject published since 1980. Of these, 3 were longitudinal studies—
2 conducted in the Seychelle Islands, and 1 in the Faroe Islands. Nine were cross-sectional studies con-
ducted in different countries where seafood, a source of MeHg, constituted a major part of the diet.
The ages of the children studied ranged from 2 weeks to 12 years. The results of the longitudinal stud-
ies were contradictory. Researchers in the Faroe Islands identiﬁed an association between MeHg expo-
sure and developmental effects, whereas those in the Seychelle Islands identiﬁed no such association.
This inconsistency was mirrored in the results of the cross-sectional studies where there were some pos-
itive and some negative ﬁndings. It was concluded that it was not possible from currently available data
to determine whether there is an association between prenatal MeHg exposure and adverse develop-
mental effects in children. In advance of future research, consideration should be given to resolving the
uncertainties surrounding exposure assessment and outcome measurement, as both elements varied
between studies. It was suggested that questions of exposure assessment would beneﬁt from the appli-
cation of an expert review process. Outcome assessment would beneﬁt from the development of theo-
retically based measures of speciﬁc aspects of cognitive functioning to replace the relatively crude
measures of attainment and IQ currently employed in most studies. This would assist in the develop-
ment of classic longitudinal studies by allowing repeated assessment over the full age range and provid-
ing data that are more readily interpretable and comparable between studies. Key words: developmental
outcomes, methylmercury, neurobehavioral tests, prenatal exposure. Environ Health Perspect
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longitudinal investigation concerned primarily
with the adverse effects of prenatal exposure to
polychlorinated biphenyls (PCBs). During the
course of this investigation, possible interac-
tions between PCB and MeHg exposure as
determinants of adverse health effects were also
investigated. Sample sizes in the cross-sectional
studies ranged from 43 to 351 and response
rates from 64 to 99% (Table 1).
Three studies were longitudinal in design
(Table 2) and followed children from birth, at
intervals, for several years. Of these, the Faroe
Islands study (Budtz-Jorgensen et al. 1999,
2000, 2002; Grandjean et al. 1992, 1995,
1997, 1998, 1999a, 2001a, 2001b, 2002a,
2002b, 2003; Murata et al. 1999a, 2002a,
2002b; Weihe et al. 1996) commenced in 1986
with a cohort of newborn infants who were
subsequently tested at ages 12 months, 7 years,
and 14 years. Two further longitudinal studies
were carried out in the Seychelle Islands. The
ﬁrst commenced in 1987 with a sample of new-
born infants who were followed up at age
5 weeks, 66 months, and 108 months
(Cernichiari et al. 1995a; Davidson et al. 2000;
Marsh et al. 1995a; Myers et al. 1995a, 1995b;
Shamlaye et al. 1995). This was considered a
pilot study by the authors, although a large
amount of data was collected of a good stan-
dard and was therefore reported. A subsequent
study commenced in the Seychelle Islands in
1989 with a sample of newborns who were fol-
lowed up at ages 6.5 months, 19 months,
29 months, 66 months, and 108 months
(Axtell et al. 1998, 2000; Cernichiari et al.
1995b; Cox et al. 1999; Crump et al. 2000;
Davidson et al. 1995a, 1995b, 1998, 1999b,
2001; Myers et al. 1995c, 1995d, 1997, 2000,
2003; Palumbo et al. 2000). Sample sizes in the
longitudinal studies were larger than those in
the cross-sectional studies (Tables 1 and 2),
although there was inevitable attrition over the
periods of longitudinal investigation (Table 2).
Exposure assessment. With the exception
of the longitudinal Faroe Islands study and the
study of Steuerwald et al. (2000), all studies
used maternal hair as the vehicle for measuring
prenatal exposure. In the case of the two longi-
tudinal Seychelle Islands studies and six of the
cross-sectional studies (Kjellstrom 1991;
Marsh et al. 1995b; McKeown-Eyssen et al.
1983; Steuerwald et al. 2000; Stewert et al.
2003; Weihe et al. 2002), hair samples were
taken from the mothers at parturition.
However, three of the cross-sectional studies
used hair samples taken from the mother
and/or the child at the time the child was
tested (Cordier et al. 2002; Grandjean et al.
1999b; Murata et al. 1999b). In the study by
Grandjean et al. (1999b), for example, expo-
sure was assessed by reference to MeHg con-
centrations in maternal hair samples and,
where this was not available, by reference to
concentrations in the child’s hair at the time
of testing. Dietary habits and social circum-
stances had changed little in the community
during the previous years. For this reason
maternal hair samples were judged likely to be
representative of parturition samples. In addi-
tion child and maternal hair concentrations
were highly correlated. Thus, where it was
necessary to use child hair samples, these were
also regarded as representing an adequate
proxy measure for maternal exposure at partu-
rition The longitudinal Faroe Islands study
and the cross-sectional study of Steuerwald
et al. (2000) used samples of cord blood as
well as maternal hair to assess levels of prenatal
exposure. All studies reported details of quality
control measures for the analysis of samples.
However, the specific form of mercury
included in the measurement was not always
clear, and a number of different exposure met-
rics were employed (Tables 1 and 2). 
Outcome measurements. A variety of out-
come measures were used that included neuro-
logic examination, developmental rating scales,
neuropsychological tests, and attainment tests.
Although this variety was accounted for partly
by the differing ages of the children, necessitat-
ing different forms of assessment, variation also
occurred between studies in terms of the tests
used for children of the same age group. All
studies used tests or rating scales that were estab-
lished, published assessment tools. With the
exception of the Seychelle Islands studies, infor-
mation on testing procedures provided in the
published reports was rather limited and there-
fore difﬁcult to evaluate. All studies reported
control of some potential effect modiﬁers such
as socioeconomic status, ethnicity, and parental
IQ, but the particular factors selected for inclu-
sion varied between studies. All studies used
multivariate analysis techniques. 
Three of the 12 studies, namely, the longi-
tudinal Faroe Islands study and the studies of
Kjellstrom (1991) and Grandjean et al.
(1999b), reported a statistically signiﬁcant rela-
tionship between prenatal exposure to MeHg
and at least one developmental outcome. In the
case of the Faroe Islands study, signiﬁcant asso-
ciations were observed for the group as a whole,
at 7 years of age, between MeHg in cord blood
Spurgeon
308 VOLUME 114 | NUMBER 2 | February 2006 • Environmental Health Perspectives
Table 1. Cross-sectional studies.
Response Age at  Exposure Exposure
Reference/country rate (%) n testing measure level Test  type
Steuerwald et al. 2000 64 182 2 weeks CB, MH 20.4 µg/L NE
Faroe Islands 4.08 µg/g
McKeown-Eyssen et al. 1983 95 234 12–30 months MH 6 µg/g NE, DS
Canada
Stewert et al. 2003 72 212 38 months MH 0.5 ng/mg PT
Canada 54 months
Marsh et al. 1995a, 1995b NS 131 NS MH 7.05 ppm NE, DM
Peru
Kjellstrom 1991 NS 237 6–7 years MH > 6 mg/kg PT, AT
Crump et al. 1998 3–6 mg/kg
New Zealand < 3 mg/kg
Murata et al. 1999a, 1999b 99 149 6–7 years MH 9.64 µg/g PT, NT
Madeira
Grandjean et al. 1999a, 1999b 84 351 7–12 years MH 11.6 µg/g PT
Brazil
Weihe et al. 2002  NS 43 7–12 years MH 15.5 µg/g PT, NT
Greenland
Cordier et al. 2002 88 97 9 months–12 years MH 12.7 µg/g NE, PT
French Guiana 85 69 6.7 µg/g
80 82 2.8 µg/g
Abbreviations: AT, attainment tests; CB, cord blood; DM, developmental milestones; DS, developmental scales; MH,
maternal hair; NE, neurologic examination; NS, not stated; NT, neurophysiologic tests; PT, psychological tests.
Table 2. Longitudinal studies.
Age at testing Response rate (%) n Exposure measure Exposure level Test type
Faroe Islands
12 months 57 583 CB, MH 121 nmol/L, 4.5 µ/g DM
7 years 90 917 CB 114 nmol/L NE, PT, NT
14 years 86 882 CB NS PT, NT
Seychelle Islands (pilot)
5–109 weeks 98 789 MH 6.6 ppm DS, NE
66 months NS 217 MH 7.1 ppm PT
108 months NS 87 MH < 3–> 9 ppm PT
Seychelle Islands (main)
6.5 months 95 740 MH 5.9 ppm VR, NE, DS
19 months 95 738 MH 5.9 ppm DM, DS
29 months 94 736 MH 5.9 ppm DS
66 months 91 711 MH 6.8 ppm PT
108 months 83 643 MH 6.9 ppm PT, TR
Abbreviations: NS, not signiﬁcant; TR, teacher rating; VR, visual recognition.and some, but not all, of the outcome measures
on six neurobehavioral tests. Many of these
associations were of borderline statistical signiﬁ-
cance. However, a dose–response relationship
between cord blood MeHg and some test out-
comes was demonstrated in a subgroup with
the highest MeHg levels. Initial analysis in the
Kjellstrom study (1991) did not indicate any
signiﬁcant associations between test outcomes
and MeHg. However, exclusion of one outlier
whose mother had particularly high MeHg lev-
els resulted in the emergence of associations
between MeHg and six test outcomes (Crump
et al. 2000; Kjellstrom 1991). In the study by
Grandjean et al. (1999b), an association
between MeHg exposure was observed for three
test outcomes. No discernible pattern was evi-
dent in these results in terms of effects on par-
ticular tests. Three further studies reported
some positive associations between MeHg
exposure and developmental outcomes,
although all qualify their conclusions and
express some reservations about the strength of
their ﬁndings. In two of these studies, children
were under 3 years of age, and assessments were
in the form of neurologic examination.
Steuerwald et al. (2000) reported that examina-
tion of children at 2 weeks of age showed that
those with higher prenatal exposures had
slightly lower overall neurologic scores,
although there was no discernible pattern of
suboptimal findings. Similarly, McKeown-
Eyssen et al. (1983) carried out neurologic
examinations on Cree Indian children between
12 and 30 months of age and found an associa-
tion between MeHg exposure and the preva-
lence of abnormal muscle tone reﬂexes in males
only. The authors note the mildness of the
abnormality, which they consider to be of
doubtful clinical significance. Cordier et al.
(2002), in a study of children 9 to 12 years of
age, found an association between scores on one
test and MeHg exposure, but this did not
appear in separate analysis of the highest
exposure subgroup. Moreover, results from one
test showed a positive association with MeHg
exposure. This type of counterintuitive result
also occurred in a study of children 7–12 years
of age (Weihe et al. 2002) and in the main
Seychelle Islands study when children were
assessed at 66 months (Davidson et al. 1998).
Neither of these studies or the ﬁrst Seychelle
Islands study report associations between other
test results and MeHg exposure. Similarly, the
results of Marsh et al. (1995b) and Murata
et al. (1999b) with children between 6 and
7 years of age indicated no associations between
psychological test scores and MeHg exposure.
Murata et al. (1999b), however, demonstrated
an effect of MeHg exposure on two neurophys-
iologic measures. Finally, the study of Stewert
et al. (2003) of younger children 38 and
54 months of age reported an interactive effect
of MeHg and PCB exposure as an incidental
ﬁnding that emerged in the course of a study to
investigate the adverse effects of PCB exposure.
A ﬁnding of this nature, although interesting,
should perhaps be regarded as speculative only
and requiring further investigation. 
Our relatively brief review of the literature
highlights the current uncertainty in this ﬁeld
of enquiry. The two major longitudinal investi-
gations report contradictory findings, and a
number of cross-sectional studies have similarly
produced inconsistent results. This data set has
already been subjected to much examination
[National Research Council (NRC) 2000] and
further analysis in an attempt to derive appro-
priate environmental exposure limits for pre-
natal MeHg (Ofﬁce of Environmental Health
1999; Rice et al. 2003). The generally assumed
superiority of longitudinal over cross-sectional
designs has tended to focus most attention on
the studies conducted in the Faroes and the
Seychelle Islands, which are of high method-
ologic quality (Jacobson 2001). However, it
should be noted that, given the complex and
challenging nature of this type of research, the
majority of the cross-sectional studies are also of
relatively good quality and would normally be
taken into account in a systematic review. The
results of these cross-sectional studies in fact
mirror the general inconsistency evident in the
results of the longitudinal investigations. One is
therefore drawn to the conclusion that it is not
possible from currently available data to deter-
mine whether prenatal exposure to MeHg, at
levels routinely experienced by populations
whose diets are rich in seafood, results in
adverse effects on the nervous system of the
developing child.
Discussion
A primary objective of the review process is the
derivation of conclusions from the available
data to guide future policy. In this case, how-
ever, the development of such a policy would
appear to be hindered by the existence of
directly contradictory results obtained from
research of equal quality. As noted above, the
data from the studies contained in this review
have already been the subject of extensive eval-
uation (NRC 2000; Rice et al. 2003) and con-
tinue to excite controversy that is so far
unresolved (Davidson et al. 1999a; Grandjean
and White 1999; Stern and Gochfeld 1999). A
secondary objective of the review process, the
identification of data gaps in the literature,
appears inappropriate in circumstances where
so much research has been carried out to date.
Although the contribution of existing pub-
lished research is unquestioned, it may be time
to concede that there is little further that can
be drawn from these data or, one suspects,
from repeated studies of a similar type.
Experience from other ﬁelds (Spurgeon 2002)
suggests that further cross-sectional studies
employing similar neurobehavioral outcomes
will serve only to increase rather than reduce
the uncertainty surrounding this issue. In the
remainder of this article, therefore, I discuss
some of the possible reasons for the inconsis-
tency in the existing data and indicate some
areas where alternative approaches might be
required to achieve some progress in this ﬁeld.
The common objective of the investigations
reviewed above was to establish whether there is
an association between prenatal exposure to
MeHg and developmental effects. Although the
various studies had many elements in common,
perhaps the most noticeable feature of the stud-
ies as a group was the variation in the methods
used to assess the two basic elements of the
association, namely, the exposure and the effect.
It is not surprising that research using different
combinations of biological and psychological
measures produces inconsistent results. The
debate surrounding each of these elements,
although undoubtedly complex, merits resolu-
tion in advance of any further research.
Exposure. In terms of the most appropriate
biological marker of prenatal exposure, opinion
is divided between maternal hair and cord
blood as the biological sample of choice.
Studies that have attempted to deﬁne the rela-
tionship between different biological indices
have produced inconsistent and somewhat
wide-ranging results, and conversion from one
set of values to another appears to involve a
number of questionable assumptions (Ofﬁce of
Environmental Health 1999). Other difﬁculties
in the interpretation of the data set arise as a
result of the use of different units of measure-
ment and a lack of clarity in some studies about
whether the measure is of organic, inorganic, or
total mercury concentration. Thus, there is
continuing uncertainty about the association
between elements of the diet and concentra-
tions in child hair, maternal hair, cord blood,
and maternal blood, as well as uncertainty
about the strength of any relationship between
each of these elements and the relationship
between each and the actual exposure of the
fetus. Elements of the debate about hair versus
blood samples must be linked to a large num-
ber of other unanswered questions surrounding
prenatal exposure measurement. These relate
particularly to the relative importance of expo-
sure at different periods of gestation, the rela-
tionship between these and average exposures,
and the importance of peak exposures. The
development of the central nervous system is
time related and unidirectional. The inhibition
of one stage of development tends to cause
alterations to subsequent processes, with limited
capacity for compensation for cell loss (Annau
and Eccles 1986; Trask and Kosofsky 2000).
Both the dose and timing of any environmental
insult are important in terms of the specific
nature of any adverse effects. How far do our
current methods of prenatal exposure assess-
ment reﬂect the need to take this into account?
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Outcomes of prenatal methylmercury exposureThe present enthusiasm for evidence-based
policy and practice appears to offer an ideal
opportunity to address these types of questions,
either through the medium of an expert work-
shop or that of a written systematic review.
The important issues in either process include
a) deﬁnition of the important questions to be
addressed to achieve valid and reliable assess-
ment of prenatal exposure, b) identiﬁcation of
available data that could be used to answer
these questions, and c) identification of new
research required to fill any identified data
gaps. In advance of some consensus on these
issues, further research is likely to provoke
more controversy rather than lead to any reso-
lution of the current uncertainty.
Outcomes. The outcomes used in these
studies were predominantly psychological tests.
Use of such tests in environmental and occupa-
tional health research, which began in the early
1980s, has always been controversial, and the
apparent inconsistencies in the data produced
has provoked much debate in both environ-
mental and occupational health research (Koller
et al. 2004; Levy et al. 2004). Results relating to
prenatal MeHg exposure represent a particular
example of a wider problem and highlight a
number of questions related to the more gen-
eral ﬁeld of neurobehavioral toxicology. 
Speciﬁcally, two main areas are of concern.
The first, and perhaps the more straight-
forward, relates to the control of variables that
either represent potential confounders or may
act as modiﬁers of the effects under investiga-
tion (Spurgeon and Gamberale 1997). They are
perhaps best considered under the broad head-
ings of situational variables (physical testing
conditions and test procedures), tester variables
(reliability of the examiners), and subject vari-
ables (individual characteristics such as age,
gender, and socioeconomic group). In all epi-
demiologic research involving psychological
testing, the list of these variables is potentially
very long, and researchers appear divided about
which to include. In research on MeHg, the
majority of studies consider important subject
characteristics such as age, ethnic and socio-
economic group, and aspects of parental
lifestyle. However, for a number of other vari-
ables (e.g., aspects of the caregiving environ-
ment), inclusion is patchy. For many of these
variables, useful literature is available on their
effects on children’s abilities or on test per-
formance, and it may be possible to reach an
evidence-based consensus on their inclusion or
exclusion. For other, mainly procedural factors,
data appear  relatively scarce. A systematic
review that encompasses other areas of psychol-
ogy, for example, that pertaining to human–
computer interaction, might reveal relevant
information. For example, how much does the
size of the screen affect performance on a com-
puter-administered test? How much does the
physical location of testing (home, laboratory,
hospital) affect test performance? Existing data
on the effects of time of day (Smith 1992), for
example, indicate that in epidemiologic studies
this factor should always be controlled.
Intuitively it would seem appropriate that the
physical testing situation and procedures should
be standardized for all subjects as far as is practi-
cally possible, regardless of whether ﬁrm evi-
dence exists about the influence of heating,
lighting, noise control, or the arrangement of
furniture. Less well-researched aspects of the
test situation can be explored usefully within
the researchers’ data. Is there, for example, a sig-
niﬁcant difference between test scores obtained
at the beginning and at the end of the week or
at different times of the year? 
The effects of the tester, particularly where
tests are not computer-administered, may be
important, not only because of different inter-
actions with different subjects but also because
of the examiner’s variable moods, motivation,
levels of fatigue, and tendency to introduce sys-
tematic errors into the testing procedure. It can-
not be assumed that conﬁning testing to one
examiner or using examiners who have under-
gone a single period of training removes tester
variation. In terms of reliability, it may be
advantageous to employ more than one tester
in some circumstances. Measures such as the
videotaping of testing procedures, double scor-
ing, and examination of the test data for trends
related to some of these factors have all been
used to account for or eliminate this potential
source of variation (Harvey et al. 1988).
Similarly some estimation, albeit a subjective
rating, of the child’s level of co-operation with
the testing procedure is important to include.
Potentially this is a major source of variation in
test performance rarely alluded to in published
reports. Ideally, tests should also include parallel
forms or practice trials to ensure that maximal
performance level is recorded for each subject. 
All except one of the studies in the ﬁeld of
research under discussion here present detailed
accounts of quality control procedures in rela-
tion to MeHg assessment. It is relatively rare to
ﬁnd equally detailed discussion of procedures
for outcome assessment. This is a situation that
occurs frequently in neurobehavioral investiga-
tions. Lack of reference to quality control does
not necessarily imply that control was limited
but may suggest something about the attitude
of researchers toward its importance. The
implications for further research are 2-fold.
First, systematic work is needed on the effects
of factors considered likely to affect test perfor-
mance, including both a review of the available
data and, if necessary, further investigative
work. Second, consensus must be reached on
good practice such as that available in some
other areas of toxicology, notably animal experi-
mentation. Although this consensus may exist
at an informal level in the ﬁeld, the consider-
able methodologic variations between different
neurobehavioral studies suggest that many
aspects are currently opinion based rather than
evidence based. 
A second and fundamental issue in terms of
outcome measures relates to the types of tests
used and, by implication, the interpretation of
the results they provide and the comparability
of these between studies. The tests employed in
the studies described above are mainly tests of
intellectual functioning. However, those used
in different studies, and sometimes within the
same study, derive from a number of separate
traditions of intellectual assessment, each of
which was developed for a different purpose
and different client group. Although each has
some advantages, none were developed speciﬁ-
cally for neurotoxicity research and none is
entirely appropriate for this type of application. 
Attainment tests are attractive in the sense
that they offer the opportunity to benchmark
the performance of children in basic skills such
as literacy and numeracy against that of their
peers. However, such tests tend to reﬂect the
use of abilities rather than the underlying abili-
ties themselves. Given the range of social and
educational factors interacting with the ability
to produce attainment, this effectively intro-
duces additional variables into the equation
(Gadzella et al. 1989). 
In contrast, the neuropsychological
approach characterized, for example, by tests
such as the Trailmaking test used in the
Seychelle Islands study or the Bender Gestalt
test used in the Faroes Islands study was devel-
oped to provide detailed evaluation of patients
with suspected damage to the brain. Such dam-
age might have resulted from head injury or
other insult or from a degenerative disease of
the nervous system. In these circumstances the
purpose of assessment is to provide detailed
information about the nature of the problem in
functional terms and thus provide a basis for
rehabilitation and progress monitoring.
Assessment in a clinical setting tends to be a
ﬂexible process that draws as much on the qual-
itative aspects of the interaction between psy-
chologist and client as it does on the numerical
test scores. The clinician is interested in the
patient as an individual and reaches a profes-
sional judgment on the basis of a number of
sources of information. There is a risk that tests
of this nature lose much of their value when
applied in a routine fashion to large groups of
people. Many who work in the ﬁeld of clinical
neuropsychology appear to be deeply uneasy
about the transfer of these techniques to an epi-
demiologic setting (British Psychological
Society 2001). Particular concern arises when
tests designed for administration by a psycholo-
gist are adapted for computer presentation.
Researchers with a neuropsychological back-
ground tend to adopt a clinical approach by
administering a very large battery of tests to
cover all aspects of functioning (Davidson et al.
Spurgeon
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1991). In an epidemiologic setting this can be
inappropriate, resulting in multiple compar-
isons and the possibility of chance findings.
Moreover, it often leads to confusion from a
psychological point of view, where the results
appear as a collection of apparently uncon-
nected ﬁndings with no discernible meaningful
pattern. Where studies use the same tests, it is
common for signiﬁcant associations to appear
in both studies but in relation to different out-
comes (Grandjean et al. 1997, 1999b). Finally,
there are questions about the ability of tests
designed for more severely affected patient
groups to detect relatively subtle effects in com-
munity samples (Spurgeon 1996; Stollery
1985, 1990).
Tests derived from a psychometric tradition
are concerned with the assessment of intelli-
gence quotients (IQ) in the general population
and were originally developed to describe nor-
mal distributions of cognitive functioning. The
Wechsler Scale (Wechsler 1991) represents the
most widely used test battery in this respect.
Developmental scales for very young children
ﬁt within this tradition, replacing formal testing
where this is impractical, although it should be
noted that maternal reports of developmental
milestones are subject to numerous sources of
error such as inaccurate recall, differing deﬁni-
tions of certain behaviors, and presentational
bias (Axelson and Rylander 1984).
The measurement of IQ is a reassuringly
familiar concept supported by a wealth of nor-
mative data and experience built up over many
years. Unfortunately, IQ tests were originally
developed within a theoretical framework of
cognitive functioning that prevailed more than
a half-century ago. Such tests reﬂected a con-
temporary need to categorize individuals on a
quantitative scale to predict future perfor-
mance, an approach now considered somewhat
crude and simplistic. Although such tests
maintain their predictive validity in some set-
tings (Neisser et al. 1996), they are relatively
blunt instruments that combine a number of
different abilities within each test (Lezak
1988). This aspect limits the information that
can be derived from the assessment and makes
interpretation difﬁcult when conﬂicting results
emerge from different studies. When placed in
the context of more recent theoretical develop-
ments in cognitive psychology, established IQ
tests do not provide results that can be easily
linked to current models of cognitive processes.
A primary objective of neurobehavioral
research is the detection of subtle effects on cog-
nitive functioning in community samples after
neurotoxicant exposure. For epidemiologic pur-
poses, tests should be quick and easy to admin-
ister. The results should be interpretable at
group level and comparable between different
studies. Given these criteria, none of the tests
currently in use appear to be entirely ﬁt for this
purpose. Speed and ease of administration do
not represent major challenges in an age of
advanced information technology. However,
improvements in interpretability and compara-
bility are more complex issues likely to require a
radical change of approach. In recent years a
number of authors have pointed to the over-
emphasis on empiricism in this ﬁeld and the
lack of a strong theoretical underpinning for the
assessment tools employed (Stephens and
Barker 1998; Stollery 1990, 1996; Williamson
1990). The development of tests grounded in
well-established cognitive theory would allow
results to be discussed in terms of the speciﬁc
aspects of cognitive processing under investiga-
tion rather than simply by reference to broad
and largely uninformative categories of effect
such as “memory” or “attention.” Modern
approaches to the study of memory processes,
for example, have long distinguished between
several elements that contribute to the ﬁnal out-
come (initial registration of information,
encoding, transfer to long-term store, loss of
information by decay or interference, and use of
cues for retrieval) (Baddeley 1987). Each may
be differentially susceptible to neurotoxic insult,
but effects on one specific process cannot be
uncovered by most current tests that provide a
simple global outcome score. Moreover, overall
scores may mask speciﬁc effects where subjects
employ compensatory strategies among differ-
ent processes to achieve maximum perfor-
mance. The development of tests, for both
children and adults, based on techniques cur-
rently available to separate and measure these
specific processes would provide much more
useful information about the nature and size of
any observed effect. This type of approach
would ultimately pave the way for much greater
comparability between the results of different
investigations and for the development of com-
parable assessment techniques for children at
different ages during longitudinal investiga-
tions. Despite much international effort during
the last 25 years, agreement on a universally
approved set of tests has proved elusive (World
Health Oganization 1989). At the same time,
the pursuit of the goal to achieve comparability
over time and between studies has tended to
inhibit the development of new techniques. It
seems unlikely that consensus on appropriate
assessment tools will be achieved in advance of
a consensus on the theoretical basis for those
tools. Fortunately, much of the information
required for these new developments is readily
available in the existing cognitive, experimental,
and developmental psychology literature. 
Conclusion
Reviews of the data relating to the developmen-
tal effects of prenatal MeHg exposure have
highlighted the inconsistency of the currently
available evidence. The size and nature of the
risk to children that is associated with seafood
consumption by their mothers remains un-
certain and a source of considerable contro-
versy. It has been argued here that the present
uncertainty derives from the variation between
studies in the methods used to measure both
the exposure and the effect. Each element
would merit further consideration in advance of
any future research in this ﬁeld. Although con-
sensus is required on the appropriate biological
marker of exposure, there is also a particular
need to address issues of both procedure and
content in psychological assessment. Discussion
of these issues, particularly those relating to psy-
chological tests, may have implications that go
well beyond the immediate needs of this ﬁeld of
inquiry. Investigation of the effects of MeHg
provides one particular example of the difﬁcul-
ties in data interpretation that occur repeatedly
in neurobehavioral studies and threaten to
undermine confidence in this methodology.
The increasing international anxiety about
potential adverse effects of low-level neurotoxi-
cant exposure in the environment underlines
the importance of addressing these concerns, as
psychological methods currently represent one
of the main tools of research in this ﬁeld.
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